+dalethyne is a segregation process of oil using oxygen, and resulting 4 major elements: peroxide, anisidine, iodine, aldehyde, that is proven to carry an antimicrobial agent against most of the bacteria, fungi, and yeasts.
Years of committed research and development has enabled Dermozone product team in inventing a process of segregating a fatty acid with the use of high-defined oxygen; that in the end resulting a function as anti-microbial, fungicidal and virucidal.
In August 2016, Immunology Team of Airlangga University, Indonesia, announced the result of “The efficacy study of active substance +dalethyne for wound incision and infected wound incision on Rattus Norvegicus”. It is found that, active substance +dalethyne is believed to be the only treatment method to combat nosocomial infection in hospital across the world.
Nosocomial Sepsis is a serious problem for patients treated in Intensive Care unit. It is associated with the increase of mortality, morbidity and the length of hospitalization which at the end cause a high increase in hospital bill. According to the 2016 WHO data, there were 7 cases of 100 patients admitted to hospital (in developing countries) and 10 cases of 100 people (in developing countries) were infected with MRSA that occur worldwide. While in developed countries, such as Europe and the USA the case were respectively 7.1% and 4.5%.
+dalethyne was founded by Kayapan Satya Dharshan, an Indonesian, who has a passion in searching and formulating an innovative solution for better global community’s health condition, especially in the area of skin care and wound care.